Dysautonomia Differentially Influences the Effect of Affective Pain Perception on Quality of Life in Parkinson’s Disease Patients

Table 1

Bivariant analysis by quality of life (PDQ-39SV > 30 versus PDQ-39SV ≤ 30) .

	PDQ-39SV ≤ 30; ()	PDQ-39SV > 30; ()
	Mean (SD)	Mean (SD)
Age	67.57 (8.94)	70.46 (8.51)	0.270
Sex (women%)	36.7	52.1	0.128
Age at PD diagnosis	59.54 (9.65)	60.13 (8.84)	0.914
Disease duration (years)	8.03 (5.04)	10.33 (5.48)	0.014
SCOPA-AUT	9.49 (5.03)	17.96 (7.51)	<0.001
UPDRS I	1.82 (2.09)	4.04 (2.35)	<0.001
UPDRS II	10.19 (4.84)	15.60 (5.39)	<0.001
UPDRS III	27.35 (9.01)	35.42 (9.69)	<0.001
UPDRS IV	2.10 (2.05)	4.89 (3.60)	<0.001
PRIS	6.16 (5.10)	9.6 (3.89)	0.001
PRIM	1.47 (1.80)	2.38 (1.88)	0.010
PRIA	1.16 (1.51)	2.42 (1.87)	<0.001
PRIT	8.80 (7.52)	14.40 (5.74)	<0.001
Daily equivalent levodopa dosage (mg)	388.02 (305.90)	666.88 (298.78)	<0.001